V. Vučinić

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Disease burden at the time of BCMA-directed chimeric antigen receptor (CAR) T-cell infusion is a key determinant of outcome in relapsed or refractory multiple myeloma (RRMM). Bridging therapy is frequently administered between leukapheresis and infusion to prevent disease progression, yet its clinical impact remains un...

Ef fi cacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma

Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

For patients with large B-cell lymphoma progressing after multiple lines of therapy few treatment options remain, including the new CD19-directed antibody-drug conjugate loncastuximab tesirine (lonca). To further elucidate its efficacy and safety, we conducted a real-world analysis including data from 31 German centers...

A decade of endemic human coronaviruses: epidemiological patterns and clinical significance in an adult cohort at a tertiary care hospital in Germany

The four endemic human coronaviruses (HCoV-OC43, -NL63, -HKU1, and − 229E) are common respiratory pathogens. Studies on HCoV epidemiology in Germany are limited. Therefore, this study aimed to characterize the epidemiology and clinical significance of HCoV-infections in adult patients over 11 seasons at a tertiary care...